Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription 15.10.2018 2 Ann Surg Oncol 4 Anticancer Res 5 BMC Cancer 2 BMC Gastroenterol 5 Br J Cancer 1 Cancer Lett 1 Dis Colon Rectum 4 Gastroenterology 16 Gastrointest Endosc 2 Int J Cancer 2 Int J Oncol 1 J Natl Cancer Inst 5 J Surg Oncol 1 N Engl J Med 1 Oncogene 2 Oncology 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Surg Oncol

1. YOKOI K, Harada H, Yokota K, Ishii S, et al
   Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.
   Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6865.
   PubMed     Text format     Abstract available
   
   
2. PINAR I, Fransgaard T, Thygesen LC, Gogenur I, et al
   Long-Term Outcomes of Robot-Assisted Surgery in Patients with Colorectal Cancer.
   Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6862.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

3. AKAMINE T, Morodomi Y, Harada Y, Teraishi K, et al
   miR-3148 Is a Novel Onco-microRNA that Potentiates Tumor Growth In Vivo.
   Anticancer Res. 2018;38:5693-5701.
   PubMed     Text format     Abstract available
   
   
4. DE CESARE M
   High Efficacy of Intravenous Gimatecan on Human Tumor Xenografts.
   Anticancer Res. 2018;38:5783-5790.
   PubMed     Text format     Abstract available
   
   
5. MURATA H, Okamoto M, Takahashi T, Motegi M, et al
   SUVmax-based Parameters of FDG-PET/CT Reliably Predict Pathologic Complete Response After Preoperative Hyperthermo-chemoradiotherapy in Rectal Cancer.
   Anticancer Res. 2018;38:5909-5916.
   PubMed     Text format     Abstract available
   
   
6. SINGH B, Singh G, Pourgholami M, Alzahrani N, et al
   Long-term Survival and Propensity Score Matched Outcomes of Bilateral vs. Unilateral Diaphragm Interventions in Cytoreductive Surgery plus Intra-peritoneal Chemotherapy.
   Anticancer Res. 2018;38:5917-5921.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

7. MIZOTA Y, Kanemitsu Y, Tsukamoto S, Shida D, et al
   ROK study-C (Rainbow of KIBOU study-colorectum): a colorectal cancer survivor cohort study on food, nutrition, physical activity, psychosocial factors and its influences on colorectal cancer recurrence, survival and quality of life in Japan.
   BMC Cancer. 2018;18:953.
   PubMed     Text format     Abstract available
   
   
8. DOTE S, Itakura S, Kamei K, Hira D, et al
   Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study.
   BMC Cancer. 2018;18:957.
   PubMed     Text format     Abstract available
   
   
9. SHI J, Fei J, Yi Q, Shen L, et al
   Treatment of colon cancer in a patient with systemic lupus erythematosus: a case report.
   BMC Cancer. 2018;18:961.
   PubMed     Text format     Abstract available
   
   
10. WANG X, Zamdborg L, Ye H, Grills IS, et al
    A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
    BMC Cancer. 2018;18:962.
    PubMed     Text format     Abstract available
    
    
11. CANTERO-CID R, Casas-Martin J, Hernandez-Jimenez E, Cubillos-Zapata C, et al
    PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
    BMC Cancer. 2018;18:945.
    PubMed     Text format     Abstract available
    
    

    
    BMC Gastroenterol

12. SHINJI S, Ueda Y, Yamada T, Koizumi M, et al
    Male sex and history of ischemic heart disease are major risk factors for anastomotic leakage after laparoscopic anterior resection in patients with rectal cancer.
    BMC Gastroenterol. 2018;18:117.
    PubMed     Text format     Abstract available
    
    
13. SAMPLE DC, Samadder NJ, Pappas LM, Boucher KM, et al
    Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients.
    BMC Gastroenterol. 2018;18:115.
    PubMed     Text format     Abstract available
    
    

    
    Br J Cancer

14. HALIM S, Markert EK, Vazquez A
    Analysis of cell proliferation and tissue remodelling uncovers a KLF4 activity score associated with poor prognosis in colorectal cancer.
    Br J Cancer. 2018 Oct 5. pii: 10.1038/s41416-018-0253.
    PubMed     Text format     Abstract available
    
    
15. BRENNER H, Chen C
    The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention.
    Br J Cancer. 2018 Oct 4. pii: 10.1038/s41416-018-0264.
    PubMed     Text format     Abstract available
    
    
16. CARVAJAL-CARMONA LG
    Moving the needle on colorectal cancer genetics: it takes more than two to TANGO.
    Br J Cancer. 2018 Oct 4. pii: 10.1038/s41416-018-0219.
    PubMed     Text format    
    
    
17. UZUNPARMAK B, Sahin IH
    Comment on "ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer".
    Br J Cancer. 2018 Oct 9. pii: 10.1038/s41416-018-0279.
    PubMed     Text format    
    
    
18. ROSEWEIR AK, McMillan DC, Edwards J
    Reply to comment of "ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer".
    Br J Cancer. 2018 Oct 9. pii: 10.1038/s41416-018-0275.
    PubMed     Text format    
    
    

    
    Cancer Lett

19. LUO Y, Chen JJ, Lv Q, Qin J, et al
    Long non-coding RNA NEAT1 promotes colorectal cancer progression by competitively binding miR-34a with SIRT1 and enhancing the Wnt/beta-catenin signaling pathway.
    Cancer Lett. 2018 Oct 9. pii: S0304-3835(18)30606.
    PubMed     Text format     Abstract available
    
    

    
    Dis Colon Rectum

20. WATANABE J, Ishibe A, Suwa Y, Suwa H, et al
    Real-Time Indocyanine Green Fluorescence Imaging-Guided Laparoscopic Right Hemicolectomy in Hepatic Flexural Colon Cancer.
    Dis Colon Rectum. 2018;61:1333-1334.
    PubMed     Text format    
    
    

    
    Gastroenterology

21. BUTT J, Varga MG, Blot WJ, Teras L, et al
    Serological response to Helicobacter pylori proteins associate with risk of colorectal cancer among diverse populations in the United States.
    Gastroenterology. 2018 Oct 5. pii: S0016-5085(18)35088.
    PubMed     Text format     Abstract available
    
    
22. DUBE C
    Organized Screening Is Better Than Opportunistic Screening at Decreasing the Burden of Colorectal Cancer in the United States.
    Gastroenterology. 2018 Oct 6. pii: S0016-5085(18)35100.
    PubMed     Text format    
    
    
23. LAVOIE S, Garrett WS
    The Story Unfolds: ATF6, Microbial Dysbiosis and Colorectal Cancer.
    Gastroenterology. 2018 Oct 6. pii: S0016-5085(18)35101.
    PubMed     Text format    
    
    
24. SCHOENFELD P
    Evidence-Based Guidelines for Screening Individuals with a Family History of Colorectal Cancer: More Questions than Answers.
    Gastroenterology. 2018 Oct 8. pii: S0016-5085(18)35104.
    PubMed     Text format    
    
    

    
    Gastrointest Endosc

25. VERSTOCKT B, Van Driessche A, De Man M, van der Spek P, et al
    Ten-year survival after endoscopic stent placement as a bridge to surgery in obstructing colon cancer.
    Gastrointest Endosc. 2018;87:705-713.
    PubMed     Text format     Abstract available
    
    
26. PARODI A, Vanbiervliet G, Hassan C, Hebuterne X, et al
    Colon capsule endoscopy to screen for colorectal neoplasia in those with family histories of colorectal cancer.
    Gastrointest Endosc. 2018;87:695-704.
    PubMed     Text format     Abstract available
    
    
27. NAGPAL SJS, Mukhija D, Sanaka M, Lopez R, et al
    Metachronous colon polyps in younger versus older adults: a case-control study.
    Gastrointest Endosc. 2018;87:657-665.
    PubMed     Text format     Abstract available
    
    
28. LEE HS, Kim SB, Lee HJ, Park SJ, et al
    Postoperative adjuvant chemotherapy is associated with a lower incidence of colorectal adenomas in patients with previous colorectal cancer.
    Gastrointest Endosc. 2018;87:688-694.
    PubMed     Text format     Abstract available
    
    
29. KIM HG, Cho YS, Cha JM, Shin JE, et al
    Risk of metachronous neoplasia on surveillance colonoscopy in young patients with colorectal neoplasia.
    Gastrointest Endosc. 2018;87:666-673.
    PubMed     Text format     Abstract available
    
    
30. BODA K, Oka S, Tanaka S, Nagata S, et al
    Clinical outcomes of endoscopic submucosal dissection for colorectal tumors: a large multicenter retrospective study from the Hiroshima GI Endoscopy Research Group.
    Gastrointest Endosc. 2018;87:714-722.
    PubMed     Text format     Abstract available
    
    
31. LI D, Woolfrey J, Jiang SF, Jensen CD, et al
    Diagnosis and predictors of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare setting.
    Gastrointest Endosc. 2018;87:755-765.
    PubMed     Text format     Abstract available
    
    
32. STIER MW, Chapman CG, Kreitman A, Hart JA, et al
    Dissection-enabled scaffold-assisted resection (DeSCAR): a novel technique for resection of residual or non-lifting GI neoplasia of the colon (with video).
    Gastrointest Endosc. 2018;87:843-851.
    PubMed     Text format     Abstract available
    
    
33. BRONZWAER MES, Musters GD, Barendse RM, Koens L, et al
    The occurrence and characteristics of endoscopically unexpected malignant degeneration in large rectal adenomas.
    Gastrointest Endosc. 2018;87:862-871.
    PubMed     Text format     Abstract available
    
    
34. KOBAYASHI R, Hirasawa K, Sato C, Makazu M, et al
    Utility of multi-detector computed tomography scans after colorectal endoscopic submucosal dissection: a prospective study.
    Gastrointest Endosc. 2018;87:818-826.
    PubMed     Text format     Abstract available
    
    
35. GUTIERREZ SANCHEZ LH, Alsawas M, Stephens M, Murad MH, et al
    Upper GI involvement in children with familial adenomatous polyposis syndrome: single-center experience and meta-analysis of the literature.
    Gastrointest Endosc. 2018;87:648-656.
    PubMed     Text format     Abstract available
    
    
36. TUTTICCI NJ, Hewett DG
    Cold EMR of large sessile serrated polyps at colonoscopy (with video).
    Gastrointest Endosc. 2018;87:837-842.
    PubMed     Text format     Abstract available
    
    
37. GRAVITO-SOARES E, Gravito-Soares M, Amaro P, Cipriano MA, et al
    Postmucosectomy colonic pseudoperforation.
    Gastrointest Endosc. 2018;87:896-897.
    PubMed     Text format    
    
    
38. KIM TJ, Kim ER, Hong SN, Kim YH, et al
    Adenoma detection rate influences the risk of metachronous advanced colorectal neoplasia in low-risk patients.
    Gastrointest Endosc. 2018;87:809-817.
    PubMed     Text format     Abstract available
    
    
39. PARK SK, Yang HJ, Jung YS, Park JH, et al
    Risk of advanced colorectal neoplasm by the proposed combined United States and United Kingdom risk stratification guidelines.
    Gastrointest Endosc. 2018;87:800-808.
    PubMed     Text format     Abstract available
    
    
40. MEHROTRA A, Morris M, Gourevitch RA, Carrell DS, et al
    Physician characteristics associated with higher adenoma detection rate.
    Gastrointest Endosc. 2018;87:778-786.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

41. VACCARO CA, Lopez-Kostner F, Valle AD, Palmero EI, et al
    From colorectal cancer pattern to the characterization of individuals at risk: picture for genetic research in Latin America.
    Int J Cancer. 2018 Oct 10. doi: 10.1002/ijc.31920.
    PubMed     Text format     Abstract available
    
    
42. RATJEN I, Shivappa N, Schafmayer C, Burmeister G, et al
    Association between the dietary inflammatory index and all-cause mortality in colorectal cancer long-term survivors.
    Int J Cancer. 2018 Oct 10. doi: 10.1002/ijc.31919.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

43. CHOWCHAIKONG N, Nilwarangkoon S, Laphookhieo S, Tanunyutthawongse C, et al
    p38 inhibitor inhibits the apoptosis of cowanin-treated human colorectal adenocarcinoma cells.
    Int J Oncol. 2018;52:2031-2040.
    PubMed     Text format     Abstract available
    
    
44. MORTENSEN AC, Spiegelberg D, Haylock AK, Lundqvist H, et al
    Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy.
    Int J Oncol. 2018;52:1875-1885.
    PubMed     Text format     Abstract available
    
    

    
    J Natl Cancer Inst

45. HAMADA T, Nowak JA, Masugi Y, Drew DA, et al
    Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells.
    J Natl Cancer Inst. 2018 Oct 11. pii: 5127125. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Surg Oncol

46. VUIJK FA, Hilling DE, Mieog JSD, Vahrmeijer AL, et al
    Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer.
    J Surg Oncol. 2018 Sep 14. doi: 10.1002/jso.25139.
    PubMed     Text format     Abstract available
    
    
47. TANG Y, Rao S, Yang C, Hu Y, et al
    Value of MRI morphologic features with pT1-2 rectal cancer in determining lymph node metastasis.
    J Surg Oncol. 2018;118:544-550.
    PubMed     Text format     Abstract available
    
    
48. HU WH, Chen HH, Yen SL, Huang HY, et al
    Re: Increased expression of interleukin-23 associated with progression of colorectal cancer. Journal of Surgical Oncology 2017;115(2):208-212.
    J Surg Oncol. 2018;118:723.
    PubMed     Text format    
    
    
49. KERANMU A, Liu HN, Wu YC, Liu TT, et al
    A negative-doughnut distal resection margin less than 5 mm does not affect prognosis in rectal cancer.
    J Surg Oncol. 2018;118:536-543.
    PubMed     Text format     Abstract available
    
    
50. HENTZEN JEKR, de Jongh SJ, Hemmer PHJ, van der Plas WY, et al
    Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review.
    J Surg Oncol. 2018;118:332-343.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

51. RUBIN AK, Burk KS, Staller K, Kunitake H, et al
    Case 30-2018: A 66-Year-Old Woman with Chronic Abdominal Pain.
    N Engl J Med. 2018;379:1263-1272.
    PubMed     Text format    
    
    

    
    Oncogene

52. DI RUOCCO F, Basso V, Rivoire M, Mehlen P, et al
    Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression.
    Oncogene. 2018;37:627-637.
    PubMed     Text format     Abstract available
    
    

    
    Oncology

53. SUZUKI T, Sadahiro S, Tanaka A, Okada K, et al
    Outcomes of Local Excision plus Chemoradiotherapy in Patients with T1 Rectal Cancer.
    Oncology. 2018;95:246-250.
    PubMed     Text format     Abstract available
    
    
54. HASS HG, Vogel U, Scheurlen M, Jobst J, et al
    Use of Gene Expression Analysis for Discrimination of Primary and Secondary Adenocarcinoma of the Liver.
    Oncology. 2018;95:211-219.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

55. VAN DER WAALS LM, Borel Rinkes IHM, Kranenburg O
    ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
    PLoS One. 2018;13:e0205536.
    PubMed     Text format     Abstract available
    
    
56. KANG S, Kim BR, Kang MH, Kim DY, et al
    Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial-mesenchymal transition in human colon cancer cells.
    PLoS One. 2018;13:e0205449.
    PubMed     Text format     Abstract available
    
    
57. SU TC, Chen CY, Tsai WC, Hsu HT, et al
    Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.
    PLoS One. 2018;13:e0204866.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: